New blood test aims to spot liver cancer recurrence early
Diagnosis
Recruiting now
This study is testing a blood test that looks for specific gene changes (methylation of GNB4 and Riplet genes) to see if it can detect when primary liver cancer comes back after treatment. The trial will follow 500 patients who had surgery, transplant, ablation, or chemoembolizat…
Sponsor: Wuhan Ammunition Life-tech Co., Ltd • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC